NCT05817227View on ClinicalTrials.gov

Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 19, 2022

Primary Completion Date

November 19, 2025

Study Completion Date

November 19, 2025

Conditions
Breast Cancer
Trial Locations (2)

80131

RECRUITING

"Istituto Nazionale Tumori - Fondazione G.Pascale, IRCCS", Napoli

00144

RECRUITING

Istituto Nazionale Tumori Regina Elena, Roma

All Listed Sponsors
lead

National Cancer Institute, Naples

OTHER

NCT05817227 - Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer. | Biotech Hunter | Biotech Hunter